lobbying_activities: 2957717

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2957717	c0067719-0f91-4171-9d00-6f52944610fe	Q1	PUBLIC STRATEGIES WASHINGTON, INC.	32486	PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA	2023	first_quarter	MMM	Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally Issues relating to biologics and biosimilars in Medicare and generally.	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2023-04-12T12:55:27-04:00